APR 03, 2016 12:16 PM PDT

Vaccine adjuvant fights infection

WRITTEN BY: Kerry Evans
Researchers from Vanderbilt University Medical Center found that a vaccine adjuvant could protect burn victims from infection.

The group found that the adjuvant monophosphoryl lipid A induces the production of granulocyte colony stimulating factor (G-CSF) to boost the production of infection-fighting neutrophils.
 
Vaccine adjuvant may protect against infection.

Lipid A is a component of lipopolysaccharide (LPS) found in Gram-negative bacteria; LPS induces a significant immune response during bacterial infection. Cells sense the presence of LPS using toll-like receptor 4, which signals the immune system that an infection is present.

Monophosphoryl lipid A (MPLA) is a component of many vaccines (anti-cancer vaccines, for example) where it is used to generate an immune response. In this application, the MPLA comes from Salmonella minnesota and has been tested in over 300,000 human subjects.

In a study published in the Journal of Leukocyte Biology, the Vanderbilt University researchers used a mouse model to test whether MPLA could help prevent infection in burn patients. They induced a burn injury in two groups of mice. One group received MPLA, and the other received only saline. The researchers then added Pseudomonas aeruginosa bacteria to the wounds and monitored how the infection spread. Mice treated with MPLA had fewer P. aeruginosa cells in their blood and lungs. They also had a higher rate of survival than saline-treated mice.

The researchers suspected that G-CSF helped stimulate neutrophils to fight infection after the mice were treated with MPLA. To test this, they blocked G-CSF production before treating the mice with MPLA. In this case, MPLA was not able to protect the mice, indicating an important role for G-CSF.

According to study author Julia Bohannon, “as a survivor of a severe burn injury myself, it is my ultimate hope that this study, and future studies that stem from these findings, will lead to effective interventions that will significantly reduce the incidence of deadly infections in burn patients, as well as other critically ill and injured patients".
 

Source: Journal of Leukocyte Biology, Lipid A in Cancer Therapy, EurekAlert, Wikipedia
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 20, 2021
Microbiology
Bacteria From Cats Could Help Treat Infections
OCT 20, 2021
Bacteria From Cats Could Help Treat Infections
Many animals, including humans and cats, harbor huge colonies of microbes, which may live in places like the skin, or th ...
OCT 22, 2021
Health & Medicine
Aromatherapy Spray Recalled Because of Deadly Bacterial Contamination
OCT 22, 2021
Aromatherapy Spray Recalled Because of Deadly Bacterial Contamination
The United States Consumer Product Safety Commission (CPSC) is warning people who purchased an aromatherapy spray called ...
NOV 05, 2021
Microbiology
Second Most Common Malaria Parasite is an Underappreciated Threat
NOV 05, 2021
Second Most Common Malaria Parasite is an Underappreciated Threat
Malaria is the most common infectious disease in the world, and infected over 225 million people in 2019 according to th ...
DEC 05, 2021
Cell & Molecular Biology
New Cell Imaging Method Sees Inside & Outside of Cell Simultaneously
DEC 05, 2021
New Cell Imaging Method Sees Inside & Outside of Cell Simultaneously
EPFL researchers have develped a new tool for viewing live cells in unprecedented detail.
DEC 09, 2021
Microbiology
Microplastics Promote Antibiotic Resistance
DEC 09, 2021
Microplastics Promote Antibiotic Resistance
Microplastics pose a clear threat to the environment. They have been found nearly everywhere, from remote areas like the ...
DEC 14, 2021
Immunology
Eye Immunity Redefined: Immune Cells Do Enter the Lens After All
DEC 14, 2021
Eye Immunity Redefined: Immune Cells Do Enter the Lens After All
The eyes may be the windows to the soul, but they are also vulnerable access points for environmental pathogens. What&rs ...
Loading Comments...